Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression

Liver International

Volumn 31, Issue 3, 2011, Pages 282-290

  Bar Yishay, Iddo ^a   Shaul, Yosef ^b   Shlomai, Amir ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Hepatitis B virus; Liver metabolism; Metabolovirus; Transcriptional regulation

Indexed keywords

ALITRETINOIN; BEZAFIBRATE; CCAAT ENHANCER BINDING PROTEIN; CLOFIBRIC ACID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIPEPTIDYL PEPTIDASE IV; FARNESOID X RECEPTOR; FORKHEAD BOX O1 PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; GLUCOCORTICOID; GLUCOSE 6 PHOSPHATASE; HEPATOCYTE NUCLEAR FACTOR; HEPATOCYTE NUCLEAR FACTOR 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (PYROPHOSPHATE); RETINOID X RECEPTOR ALPHA; ROSIGLITAZONE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CELL METABOLISM; GENE EXPRESSION; HEPATITIS B VIRUS; HUMAN; IN VIVO STUDY; LIVER CELL; LIVER METABOLISM; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VIRUS EXPRESSION; VIRUS GENE; VIRUS REPLICATION;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, VIRAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 79551569966     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02423.x     Document Type: Review

References (100)

1. Ganem D, Prince AM. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004; 350: 1118-29.
2. Block TM, Guo H, Guo JT. Molecular virology of hepatitis B virus for clinicians. Clin Liver Dis 2007; 11: 685-706.
3. Shaul Y, Rutter WJ, Laub O. A human hepatitis B viral enhancer element. EMBO J 1985; 4: 427-30.
4. Raney AK, Kline EF, Tang H, Mclachlan A. Transcription and replication of a natural hepatitis B virus nucleocapsid promoter variant is regulated in vivo by peroxisome proliferators. Virology 2001; 289: 239-51.
5. Wang Y, Chen P, Wu X, et al. A new enhancer element, ENII, identified in the X gene of hepatitis B virus. J Virol 1990; 64: 3977-81.
6. Yee JK. A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science 1989; 246: 658-61.
7. Yuh CH, Ting LP. The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function. J Virol 1990; 64: 4281-7.
8. Lopez-Cabrera M, Letovsky J, Hu KQ, Siddiqui A. Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus. Virology 1991; 183: 825-9.
9. Ben-Levy R, Faktor O, Berger I, Shaul Y. Cellular factors that interact with the hepatitis B virus enhancer. Mol Cell Biol 1989; 9: 1804-9.
10. Fukai K, Takada S, Yokosuka O, et al. Characterization of a specific region in the hepatitis B virus enhancer I for the efficient expression of X gene in the hepatic cell. Virology 1997; 236: 279-87.
11. Johnson JL, Raney AK, Mclachlan A. Characterization of a functional hepatocyte nuclear factor 3 binding site in the hepatitis B virus nucleocapsid promoter. Virology 1995; 208: 147-58.
12. Li M, Xie Y, Wu X, Kong Y, Wang Y. HNF3 binds and activates the second enhancer, ENII, of hepatitis B virus. Virology 1995; 214: 371-8.
13. Ori A, Shaul Y. Hepatitis B virus enhancer binds and is activated by the Hepatocyte nuclear factor 3. Virology 1995; 207: 98-106.
14. Ramiere C, Scholtes C, Diaz O, et al. Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha. J Virol 2008; 82: 10832-40.
15. Raney AK, Johnson JL, Palmer CN, Mclachlan A. Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter. J Virol 1997; 71: 1058-71.
16. Shlomai A, Shaul Y. The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription. Biochem Biophys Res Commun 2009; 381: 544-8.
17. Doitsh G, Shaul Y. Enhancer I predominance in hepatitis B virus gene expression. Mol Cell Biol 2004; 24: 1799-808.
18. Gross DN, Van den Heuvel AP, Birnbaum MJ. The role of FoxO in the regulation of metabolism. Oncogene 2008; 27: 2320-36.
19. Edwards PA, Kast HR, Anisfeld AM. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J Lipid Res 2002; 43: 2-12.
20. Sinal CJ, Tohkin M, Miyata M, et al. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000; 102: 731-44.
21. Mitchell SM, Frayling TM. The role of transcription factors in maturity-onset diabetes of the young. Mol Genet Metab 2002; 77: 35-43.
22. Shlomai A, Paran N, Shaul Y. PGC-1alpha controls hepatitis B virus through nutritional signals. Proc Natl Acad Sci USA 2006; 103: 16003-8.
23. Kim HY, Cho HK, Choi YH, Lee KS, Cheong J. Bile acids increase hepatitis B virus gene expression and inhibit interferon-alpha activity. FEBS J 2010; 277: 2791-802.
24. Kim K, Kim KH, Kim HH, Cheong J. Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRalpha. Biochem J 2008; 416: 219-30.
25. Kim KH, Shin HJ, Kim K, et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology 2007; 132: 1955-67.
26. Shlomai A, Shaul Y. The 'metabolovirus' model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon. Med Hypotheses 2008; 71: 53-7.
27. Schrem H, Klempnauer J, Borlak J. Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol Rev 2002; 54: 129-58.
28. Nagy P, Bisgaard HC, Thorgeirsson SS. Expression of hepatic transcription factors during liver development and oval cell differentiation. J Cell Biol 1994; 126: 223-33.
29. Wang JC, Stafford JM, Scott DK, Sutherland C, Granner DK. The molecular physiology of hepatic nuclear factor 3 in the regulation of gluconeogenesis. J Biol Chem 2000; 275: 14717-21.
30. Rhee J, Inoue Y, Yoon JC, et al. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci USA 2003; 100: 4012-7.
31. Nakao K, Miyao Y, Ohe Y, Tamaoki T. Involvement of an AFP1-binding site in cell-specific transcription of the pre-S1 region of the human hepatitis B virus surface antigen gene. Nucleic Acids Res 1989; 17: 9833-42.
32. Raney AK, Easton AJ, Milich DR, Mclachlan A. Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1. J Virol 1991; 65: 5774-81.
33. Wang WX, Li M, Wu X, Wang Y, Li ZP. HNF1 is critical for the liver-specific function of HBV enhancer II. Res Virol 1998; 149: 99-108.
34. Gunther S, Piwon N, Iwanska A, et al. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J Virol 1996; 70: 8318-31.
35. Raney AK, Eggers CM, Kline EF, et al. Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice. J Virol 2001; 75: 2900-11.
36. Chen M, Hieng S, Qian X, Costa R, Ou JH. Regulation of hepatitis B virus ENI enhancer activity by hepatocyte-enriched transcription factor HNF3. Virology 1994; 205: 127-32.
37. Banks KE, Anderson AL, Tang H, et al. Hepatocyte nuclear factor 3beta inhibits hepatitis B virus replication in vivo. J Virol 2002; 76: 12974-80.
38. Tang H, Mclachlan A. Mechanisms of inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by hepatocyte nuclear factor 3beta. J Virol 2002; 76: 8572-81.
39. Yu X, Mertz JE. Distinct modes of regulation of transcription of hepatitis B virus by the nuclear receptors HNF4alpha and COUP-TF1. J Virol 2003; 77: 2489-99.
40. Bock CT, Malek NP, Tillmann HL, Manns MP, Trautwein C. The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro. J Virol 2000; 74: 2193-202.
41. Guo W, Chen M, Yen TS, Ou JH. Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation. Mol Cell Biol 1993; 13: 443-8.
42. Li L, Oropeza CE, Sainz B Jr, et al. Developmental regulation of hepatitis B virus biosynthesis by hepatocyte nuclear factor 4alpha. PLoS One 2009; 4: e5489.
43. Cai YN, Zhou Q, Kong YY, et al. LRH-1/hB1F and HNF1 synergistically up-regulate hepatitis B virus gene transcription and DNA replication. Cell Res 2003; 13: 451-8.
44. Tang H, Mclachlan A. Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc Natl Acad Sci USA 2001; 98: 1841-6.
45. Michalik L, Auwerx J, Berger JP, et al. International union of pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev 2006; 58: 726-41.
46. Huan B, Kosovsky MJ, Siddiqui A. Retinoid X receptor alpha transactivates the hepatitis B virus enhancer 1 element by forming a heterodimeric complex with the peroxisome proliferator-activated receptor. J Virol 1995; 69: 547-51.
47. Guidotti LG, Eggers CM, Raney AK, et al. In vivo regulation of hepatitis B virus replication by peroxisome proliferators. J Virol 1999; 73: 10377-86.
48. Wakui Y, Inoue J, Ueno Y, et al. Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone. Biochem Biophys Res Commun 2010; 396: 508-14.
49. Makishima M, Okamoto AY, Repa JJ, et al. Identification of a nuclear receptor for bile acids. Science 1999; 284: 1362-5.
50. Parks DJ, Blanchard SG, Bledsoe RK, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999; 284: 1365-8.
51. Forman BM, Goode E, Chen J, et al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 1995; 81: 687-93.
52. Chang KO, George DW. Bile acids promote the expression of hepatitis C virus in replicon-harboring cells. J Virol 2007; 81: 9633-40.
53. Chang KO. Role of cholesterol pathways in norovirus replication. J Virol 2009; 83: 8587-95.
54. Goodwin B, Jones SA, Price RR, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000; 6: 517-26.
55. Ondracek CR, Rushing CN, Reese VC, Oropeza CE, Mclachlan A. Peroxisome proliferator-activated receptor gamma Coactivator 1alpha and small heterodimer partner differentially regulate nuclear receptor-dependent hepatitis B virus biosynthesis. J Virol 2009; 83: 12535-44.
56. Chen W, Liu J, Gluud C. Bile acids for viral hepatitis. Cochrane Database Syst Rev 2007; CD003181.
57. Barone M, Maiorano E, Ladisa R, et al. Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice. Hepatology 2003; 37: 880-6.
58. Southgate RJ, Bruce CR, Carey AL, et al. PGC-1alpha gene expression is down-regulated by Akt- mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle. FASEB J 2005; 19: 2072-4.
59. Bastie CC, Nahle Z, Mcloughlin T, et al. FoxO1 stimulates fatty acid uptake and oxidation in muscle cells through CD36-dependent and -independent mechanisms. J Biol Chem 2005; 280: 14222-9.
60. Furuyama T, Kitayama K, Yamashita H, Mori N. Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. Biochem J 2003; 375 (Pt 2): 365-71.
61. Hall RK, Yamasaki T, Kucera T, et al. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins. J Biol Chem 2000; 275: 30169-75.
62. Schmoll D, Walker KS, Alessi DR, et al. Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. J Biol Chem 2000; 275: 36324-33.
63. Daitoku H, Yamagata K, Matsuzaki H, Hatta M, Fukamizu A. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes 2003; 52: 642-9.
64. Gripon P, Diot C, Corlu A, Guguen-Guillouzo C. Regulation by dimethylsulfoxide, insulin, and corticosteroids of hepatitis B virus replication in a transfected human hepatoma cell line. J Med Virol 1989; 28: 193-9.
65. Guo H, Zhou T, Jiang D, et al. Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway. J Virol 2007; 81: 10072-80.
66. Vinson GP. The adrenal cortex and life. Mol Cell Endocrinol 2009; 300: 2-6.
67. Tur-Kaspa R, Burk RD, Shaul Y, Shafritz DA. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci USA 1986; 83: 1627-31.
68. Tur-Kaspa R, Laub O. Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system. J Hepatol 1990; 11: 34-6.
69. Tur-Kaspa R, Shaul Y, Moore DD, et al. The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology 1988; 167: 630-3.
70. Hoofnagle JH. Reactivation of hepatitis B. Hepatology 2009; 49 (Suppl.): S156-65.
71. Shibolet O, Ilan Y, Gillis S, et al. Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. Blood 2002; 100: 391-6.
72. Montminy MR, Bilezikjian LM. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 1987; 328: 175-8.
73. Herzig S, Hedrick S, Morantte I, et al. CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma. Nature 2003; 426: 190-3.
74. Herzig S, Long F, Jhala US, et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001; 413: 179-83.
75. Faktor O, Budlovsky S, Ben-Levy R, Shaul Y. A single element within the hepatitis B virus enhancer binds multiple proteins and responds to multiple stimuli. J Virol 1990; 64: 1861-3.
76. Kim BK, Lim SO, Park YG. Requirement of the cyclic adenosine monophosphate response element-binding protein for hepatitis B virus replication. Hepatology 2008; 48: 361-73.
77. Tacke F, Liedtke C, Bocklage S, Manns MP, Trautwein C. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter. Gut 2005; 54: 1309-17.
78. Puigserver P, Wu Z, Park CW, et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998; 92: 829-39.
79. Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005; 1: 361-70.
80. Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 2006; 27: 728-35.
81. Yoon JC, Puigserver P, Chen G, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001; 413: 131-8.
82. Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 2000; 20: 1868-76.
83. Knutti D, Kaul A, Kralli A. A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen. Mol Cell Biol 2000; 20: 2411-22.
84. Zhang Y, Castellani LW, Sinal CJ, Gonzalez FJ, Edwards PA. Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev 2004; 18: 157-69.
85. Rechtman MM, Har-Noy O, Bar-Yishay I, et al. Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha. FEBS Lett 2010; 584: 2485-90.
86. Li L, Oropeza CE, Kaestner KH, Mclachlan A. Limited effects of fasting on hepatitis B virus (HBV) biosynthesis in HBV transgenic mice. J Virol 2009; 83: 1682-8.
87. Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 2001; 36: 651-60.
88. Haviv I, Vaizel D, Shaul Y. The X protein of hepatitis B virus coactivates potent activation domains. Mol Cell Biol 1995; 15: 1079-85.
89. Maguire HF, Hoeffler JP, Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 1991; 252: 842-4.
90. Reddi H, Kumar R, Jain SK, Kumar V. A carboxy-terminal region of the hepatitis B virus X protein promotes DNA interaction of CREB and mimics the native protein for transactivation function. Virus Genes 2003; 26: 227-38.
91. Negro F, Sanyal AJ. Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data. Liver Int 2009; 29 (Suppl. 2): 26-37.
92. Serfaty L, Capeau J. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data. Liver Int 2009; 29 (Suppl. 2): 13-25.
93. Huang ZS, Huang TS, Wu TH, et al. Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: a ten-year observation. J Gastroenterol Hepatol 2010; 25: 1420-5.
94. Lee YI, Kang-Park S, Do SI. The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 2001; 276: 16969-77.
95. Hajjou M, Norel R, Carver R, et al. cDNA microarray analysis of HBV transgenic mouse liver identifies genes in lipid biosynthetic and growth control pathways affected by HBV. J Med Virol 2005; 77: 57-65.
96. Gavrilova O, Haluzik M, Matsusue K, et al. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem 2003; 278: 34268-76.
97. Yu S, Matsusue K, Kashireddy P, et al. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem 2003; 278: 498-505.
98. Choi BH, Park GT, Rho HM. Interaction of hepatitis B viral X protein and CCAAT/enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter. J Biol Chem 1999; 274: 2858-65.
99. Dikstein R, Faktor O, Shaul Y. Hierarchic and cooperative binding of the rat liver nuclear protein C/EBP at the hepatitis B virus enhancer. Mol Cell Biol 1990; 10: 4427-30.
100. Unger T, Shaul Y. The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element. EMBO J 1990; 9: 1889-95.